News for NeuroPace, Inc. (NPCE)

-- Minimal expected impact to operations and financial results -- -- Company to report first quarter 2025 financial results on May 13, 2025 -- MOUNTAIN VIEW,

NeuroPace (NPCE) has announced that despite the recent implementation of tariffs, it foresees negligible effects on its operations and financial performance. Th

**media[594888]**

U.S. stock futures were lower this morning, with the Dow futures falling more than 600 points on Wednesday. Shares of Kura Sushi USA Inc KRUS fell sharply in t...

Three-year data from NeuroPace's Post-Approval Study of the RNS® System in drug-resistant focal epilepsy to be shared in oral presentation MOUNTAIN VIEW, Cal

**media[584958]**

-- Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 -- -- Maintaining 2025 Revenue Guidance -- -- No Change to Long-Range Plan

**media[584438]**

**media[582963]**

Shares of NeuroPace Inc (NPCE) fell 4.25% in mid-day trading on Mar 27. The stock reached an intraday low of $12.16, before recovering slightly to $12.18, d

**media[577178]**

Operator: Greetings, and welcome to the NeuroPace Fourth Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.

Total Revenue (2024): $79.9 million, a 22% increase from $65.4 million in 2023.Q4 Revenue (2024): $21.5 million, a 19% increase from $18 million in Q4 2023.Gro

NeuroPace, Inc. (NASDAQ:NPCE) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ETCompany ParticipantsJeremy Feffer - Investor RelationsJoel Becker -...

-- Record quarterly revenue of $21.5 million in Q4 2024 -- -- Full-year 2025 revenue guidance of $92 to $96 million -- -- Completed an underwritten public off

Quarterly Revenue: Achieved $21.5 million in Q4 2024, surpassing the estimated $21.17 million.Earnings Per Share (EPS): Reported a net loss of $0.18 per share,

The following slide deck was published by NeuroPace, Inc.

MOUNTAIN VIEW, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people

MOUNTAIN VIEW, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. ( NPCE), a medical device company focused on transforming the lives of people living